This cluster exists because people researching QUAD also see MEDVi weight-loss ads. The GLP-1 line is the exact area the 2026 FDA warning letter addressed. Stick to sourced facts.
Is MEDVi Compounded Tirzepatide the Same as Mounjaro?
No. Approved tirzepatide pens are finished FDA-approved drugs. Compounded versions are not those pens, even if they share an active-ingredient name. FDA has warned companies about implying equivalence.
| Product type | Example | Finished-product FDA approval? |
|---|---|---|
| Approved incretin pens | Wegovy, Ozempic, Mounjaro, Zepbound (labels differ) | Yes, as those branded/generic approved products |
| Compounded GLP-1 | Telehealth compounded vials/troches etc. | No, as a finished compounded product |
Letter explainer · Is MEDVi tirzepatide safe? · FDA-approved options overview
Sources Checked for This Page
- FDA warning letter MEDVi 721455 (20 February 2026) where GLP-1 claims are discussed.
- FDA labels for sildenafil, tadalafil, bremelanotide; FDA pages on compounding vs approval.
- Brand-facing MEDVi safety/pharmacy copy naming Belmar in GLP-1 materials, treated as company statements.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines. For product-level depth, use the flagship MEDVi QUAD review.